Weill Cornell Medicine Enterprise Innovation

Weill Cornell Medicine Enterprise Innovation provides a bridge between academic researchers and industry and investment stakeholders. We educate researchers about biomedical commercialization and business development while also brokering engagements and alliances with industry. Our focus is to translate innovative science and technologies into world-class medical breakthroughs. Our team of top-tier business development experts works collaboratively with a network of partners to commercialize technologies across major pillars of biomedical innovation.

We are part of Weill Cornell Medicine, the medical college of Cornell University. We connect interested collaborators to the broader Weill Cornell ecosystem for access to core facilities, researchers, clinical trials, etc. We have a robust IP portfolio that encompasses therapeutics, devices, diagnostics and precision medicine, tangible properties, digital health and data assets. We always welcome NYC companies to connect with us as a source of assets to build and grow their pipelines.